Stocks and Investing
Stocks and Investing
Tue, July 26, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joshua Jennings Maintained (TMDX) at Buy with Increased Target to $45 on, Jul 26th, 2022
Joshua Jennings of Cowen & Co., Maintained "TransMedics Group, Inc." (TMDX) at Buy with Increased Target from $39 to $45 on, Jul 26th, 2022.
Joshua has made no other calls on TMDX in the last 4 months.
There is 1 other peer that has a rating on TMDX. Out of the 1 peers that are also analyzing TMDX, all agrees with Joshua's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $34 on, Wednesday, June 29th, 2022
Contributing Sources